- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
Valeant to acquire Toronto maker of derm products
Aliso Viejo, Calif. - Valeant Pharmaceuticals, based here, will acquire Vital Science Corp., a Toronto-based manufacturer of over-the-counter dermatology products, news source Socaltech.com reports.
Aliso Viejo, Calif. - Valeant Pharmaceuticals, based here, will acquire Vital Science Corp., a Toronto-based manufacturer of over-the-counter dermatology products, news source Socaltech.com reports.
Valeant officials say the deal is worth about $10.5 million in Canadian dollars. They expect closing to occur in the second quarter, according to the report.
Valeant acquired two other dermatology firms, both in Brazil, earlier this year.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
